Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort (Q35789263)

10 August 2017

Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort (English)

1 reference

10 August 2017

0 references

1 reference

11

Kenneth W Mahaffey

1 reference

10 August 2017

2

Gregg C Fonarow

1 reference

10 August 2017

13

Eric D Peterson

1 reference

10 August 2017

14

Jonathan P Piccini

1 reference

10 August 2017

7

Bernard J Gersh

1 reference

10 August 2017

1

Larry A Allen

1 reference

10 August 2017

6

Sean D Pokorney

1 reference

10 August 2017

10

Peter R Kowey

1 reference

10 August 2017

9

Elaine M Hylek

1 reference

10 August 2017

ORBIT-AF Investigators

series ordinal

15

object named as

ORBIT-AF Investigators

1 reference

10 August 2017

3

DaJuanicia N Simon

1 reference

10 August 2017

8

Alan S Go

1 reference

10 August 2017

Laine E Thomas

4

1 reference

10 August 2017

Lucas N Marzec

series ordinal

5

1 reference

10 August 2017

Paul Chang

series ordinal

12

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2015

1 reference

Journal of the American College of Cardiology

10 August 2017

1 reference

10 August 2017

65

1 reference

10 August 2017

25

1 reference

10 August 2017

2691-2698

1 reference

Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Cardiac glycoside toxicity: more than 200 years and counting

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Primer on statistical interpretation or methods report card on propensity-score matching in the cardiology literature from 2004 to 2006: a systematic review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Ethics and regulatory complexities for pragmatic clinical trials.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Effectiveness and safety of digoxin among contemporary adults with incident systolic heart failure.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Contemporary use of digoxin in the management of cardiovascular disorders

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4483195

The effect of digoxin on mortality and morbidity in patients with heart failure

25 September 2018

1 reference

12 December 2020

Sex-based differences in the effect of digoxin for the treatment of heart failure

1 reference

12 December 2020

Increased mortality among patients taking digoxin--analysis from the AFFIRM study

1 reference

12 December 2020

Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial

1 reference

12 December 2020

A sequential stratification method for estimating the effect of a time-dependent experimental treatment in observational studies

1 reference

12 December 2020

10.1016/J.JACC.2015.04.045

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference